Protective immunity against severe malaria is associated with antibodies to a conserved repertoire of PfEMP1 variants
Authors:
- Sofonias K. TessemaSTSofonias K. Tessema
- Rie NakajimaRNRie Nakajima
- Algis JasinskasAJAlgis Jasinskas
- Stephanie L. MonkSMStephanie L. Monk
- Lea LekieffreLLLea Lekieffre
- Enmoore LinELEnmoore Lin
- Benson KiniboroBKBenson Kiniboro
- Carla ProiettiCPCarla Proietti
- Peter M SibaPSPeter M Siba
- Philip L. FelgnerPFPhilip L. Felgner
- Denise L. DoolanDDDenise L. Doolan
- Ivo MuellerIMIvo Mueller
Preprint
Abstract
Extreme diversity of the major surface antigen and virulence determinant of the malaria parasite Plasmodium falciparum , Erythrocyte Membrane Protein-1 (PfEMP1), poses a major barrier to identifying targets of protective immunity. To overcome this problem, we developed a PfEMP1 protein microarray containing 456 DBLα domains, which was used to characterize the immunome of a cohort of semi-immune children and to identify variants associated with protective immune responses. Children with high mean antibody levels to DBLα group 2 had a 26-36% reduced risk of uncomplicated (clinical) malaria, however only 8 diverse DBLα variants were weakly associated with protection from clinical malaria and had low predictive accuracy. On the other hand, children with high mean antibodies to DBLα groups 1 and 2 (which are markers for pathogenic “Type A” PfEMP1) and elevated antibodies to 85 (18.6%) of individual DBLα variants had a 70 −100% reduced risk of severe malaria. Of the top 20 predictive variants for severe disease protection, 17 were strongly associated with protection (86 - 100% reduction in risk of severe malaria) and had high predictive accuracy for severe disease risk. Many variants were conserved and had highly correlated antibody responses, including the three highest-ranking variants, which were linked to EPCR-binding CIDR domains. The results suggest that while immunity to uncomplicated malaria is characterised by antibodies to a diverse repertoire of PfEMP1, immunity to severe malaria requires antibodies to a limited subset of antigenically conserved variants. These findings provide new insights into antimalarial immunity and potential biomarkers for tracking disease risk.Keywords
All Related Versions
- Published version: Cell Host & Microbe, 26 (5), 579.
This publication has 63 references indexed in Scilit:
- Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in childrenProceedings of the National Academy of Sciences, 2012
- A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarrayProceedings of the National Academy of Sciences, 2010
- Plasmodium falciparum var gene expression is modified by host immunityProceedings of the National Academy of Sciences, 2009
- Adhesion ofPlasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implicationsExpert Reviews in Molecular Medicine, 2009
- Profiling humoral immune responses to P. falciparum infection with protein microarraysProteomics, 2008
- PfEMP1-DBL1α amino acid motifs in severe disease states of Plasmodium falciparum malariaProceedings of the National Academy of Sciences, 2007
- An approach to classifying sequence tags sampled from Plasmodium falciparum var genesMolecular and Biochemical Parasitology, 2007
- Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemiaMolecular and Biochemical Parasitology, 2006
- Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malariaMolecular Microbiology, 2003
- The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytesCell, 1995